Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations

Biochemical and Biophysical Research Communications

Volumn 294, Issue 4, 2002, Pages 798-805

  Halseth, Amy E ^a   Ensor, Nancy J ^a   White, Tommi A ^a   Ross, Stuart A ^a   Gulve, Eric A ^a  

^a Cardiovascular Diseases Research   (United States)

Author keywords

5 AMP activated kinase; Diabetes; Glut4; Skeletal muscle; Triglycerides

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; GLUCOSE TRANSPORTER 4; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LONG TERM CARE; MALE; MOUSE; MOUSE STRAIN; MUSCLE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOSINE MONOPHOSPHATE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, OBESE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLES; RIBONUCLEOTIDES; TIME FACTORS; TRIGLYCERIDES;

ANIMALIA;

EID: 0036289911     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00557-0     Document Type: Article

References (32)

1. Effect of AMPK activation on muscle glucose metabolism in conscious rats
2. Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats
3. Chronic treatment with 5-aminoimimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner
4. Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone
5. Hepatic metabolism of genetically diabetic (db/db) mice. I. Carbohydrate metabolism
6. AMPK signaling in contracting human skeletal muscle: Acetyl-CoA carboxylase and NO synthase phosphorylation
7. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase
8. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle
9. Pharmacokinetics and clinical efficacy of pioglitazone
10. The AMP-activated protein kinase. Fuel gauge of the mammalian cell?
11. Evidence for 5′AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport
12. Exercise regulation of glucose transport in skeletal muscle
13. Metabolic effects of physical training
14. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle
15. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase
16. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with Type 2 diabetes
17. Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice
18. Metformin reverses fatty liver disease in obese, leptindeficient mice
19. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase
20. Gluconeogenesis in perfused livers of genetically obese-hyperglycemic (ob/ob) mice
21. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
22. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: Evidence that sn-glycerol-3-phosphate acyltransferase is a novel target
23. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro
24. Glucose utilization
25. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice
26. Hypoglycaemic effect of AICA riboside in mice
27. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes
28. A review of rosiglitazone in type 2 diabetes mellitus
29. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes
30. Inactivation of acetly-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise
31. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle
32. Role of AMP-activated protein kinase in mechanism of metformin action